Clinical Trials on 铂耐药复发性卵巢癌 in Korea, Democratic People's Republic of
总计221个结果
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean Gynecologic Oncology... 和其他合作者招聘中
-
Yonsei UniversityTakeda招聘中既往接受过 PARP 抑制剂治疗的铂敏感复发性卵巢癌患者大韩民国
-
Yonsei UniversityCanariaBio Inc.招聘中PARP 抑制剂耐药的卵巢癌、输卵管癌或原发性腹膜癌患者不适合铂类再治疗大韩民国
-
Yonsei University招聘中
-
Seoul National University HospitalBoryung Pharmaceutical Co., Ltd主动,不招人
-
Yonsei University撤销
-
Seoul National University HospitalRF medical招聘中
-
Seoul National University Hospital招聘中
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National University Hospital 和其他合作者未知卵巢癌IIIC期 | 卵巢癌第四期大韩民国
-
Konkuk University Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Asan Medical Center; Seoul National University... 和其他合作者完全的
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Seoul St. Mary's Hospital; Pusan National... 和其他合作者完全的
-
The Catholic University of KoreaKorean Cancer Study Group完全的
-
CanariaBio Inc.Korean Cancer Study Group招聘中
-
Korea University Guro HospitalYonsei University; Boryung Pharmaceutical Co., Ltd; Chong Kun Dang Pharmaceutical Corp.招聘中
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)完全的
-
CellabMEDYooyoung Pharmaceutical Co., Ltd.完全的
-
Seoul National University HospitalSamyang Biopharmaceuticals Corporation完全的
-
Samsung Medical CenterMerck Sharp & Dohme LLC完全的
-
Seoul National University Hospital未知